160 related articles for article (PubMed ID: 1251567)
21. Stability of red cell antigens and plasma coagulation factors stored in new formulation plastic blood containers.
Snyder EL; Hezzey A; Weirich F; Mosher DF; Davisson W; Buchholz DH
Transfusion; 1983; 23(1):49-53. PubMed ID: 6829059
[TBL] [Abstract][Full Text] [Related]
22. Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant.
Suontaka AM; Akerblom O; Blombäck M; Eriksson L; Högman CF; Payrat JM
Vox Sang; 1996; 71(2):97-102. PubMed ID: 8873419
[TBL] [Abstract][Full Text] [Related]
23. Can storage of thawed cryoprecipitate be extended to more than six hours?
Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
[TBL] [Abstract][Full Text] [Related]
24. The influence of donor characteristics and preparation methods on the potency of human cryoprecipitate.
Burka ER; Puffer T; Martinez J
Transfusion; 1975; 15(4):323-8. PubMed ID: 1166505
[TBL] [Abstract][Full Text] [Related]
25. Microwave-thawed plasma for cryoprecipitate production.
Bass H; Trenchard PM; Mustow MJ
Vox Sang; 1985; 48(2):65-71. PubMed ID: 3934842
[TBL] [Abstract][Full Text] [Related]
26. Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII.
Mason EC
Lancet; 1978 Jul; 2(8079):15-7. PubMed ID: 78212
[TBL] [Abstract][Full Text] [Related]
27. Freezing of plasma and recovery of factor VIII.
Carlebjörk G; Blombäck M; Pihlstedt P
Transfusion; 1986; 26(2):159-62. PubMed ID: 3082044
[TBL] [Abstract][Full Text] [Related]
28. An improved thaw-siphon method for the cryoprecipitate preparation.
Kang EP
Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
[TBL] [Abstract][Full Text] [Related]
29. A protocol for cryoprecipitate production.
Burka ER; Harker LA; Kasper CK; Kevy SV; Ness PM
Transfusion; 1975; 15(4):307-11. PubMed ID: 1166503
[TBL] [Abstract][Full Text] [Related]
30. A protocol for the preparation of cryoprecipitate and cryodepleted plasma.
Sparrow RL; Greening DW; Simpson RJ
Methods Mol Biol; 2011; 728():259-65. PubMed ID: 21468954
[TBL] [Abstract][Full Text] [Related]
31. The effect of Na3-citrate on the solubility of cryoprecipitate (citrate effect on cryoprecipitate).
Faludi E; Harsányi V
Haematologia (Budap); 1981; 14(2):207-14. PubMed ID: 6792005
[TBL] [Abstract][Full Text] [Related]
32. A Protocol for the Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Studies.
Sparrow RL; Simpson RJ; Greening DW
Methods Mol Biol; 2017; 1619():23-30. PubMed ID: 28674874
[TBL] [Abstract][Full Text] [Related]
33. Preparation of pooled cryoprecipitate for treatment of hemophilia A in a home care program.
Smith KJ; Hodges PA
Transfusion; 1984; 24(6):520-3. PubMed ID: 6438840
[TBL] [Abstract][Full Text] [Related]
34. Effect of whole blood storage on factor VIII recovery in fresh frozen plasma and cryoprecipitate.
Allersma DP; Imambaks RM; Meerhof LJ
Vox Sang; 1996; 71(3):150-4. PubMed ID: 8912457
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of factor VIII-rich cryoprecipitate and the plasma fibronectin-rich, heparin-precipitable fraction prepared from single-donor plasma units.
Menitove JE; Amrani DL; Meh D; Frenzke M; Mosesson MW
Transfusion; 1987; 27(6):491-5. PubMed ID: 3500532
[TBL] [Abstract][Full Text] [Related]
36. Shelf-life of bank blood and stored plasma with special reference to coagulation factors.
Nilsson L; Hedner U; Nilsson IM; Robertson B
Transfusion; 1983; 23(5):377-81. PubMed ID: 6414128
[TBL] [Abstract][Full Text] [Related]
37. Cryoprecipitated antihemophilic factor production from blood collected in quad packs or from blood with delayed processing. The importance of plasma thawing method.
Orthner CL; MacPherson JL
Transfusion; 1984; 24(6):516-9. PubMed ID: 6438839
[TBL] [Abstract][Full Text] [Related]
38. [Factors controlling the isolation of factor VIII from cryoprecipitate].
Tarasova LN
Gematol Transfuziol; 1989 Feb; 34(2):54-7. PubMed ID: 2496004
[No Abstract] [Full Text] [Related]
39. Factor VIII collection by pheresis.
McLeod BC; Sassetti RJ; Cole ER; Pierce MI
Lancet; 1980 Sep; 2(8196):671-3. PubMed ID: 6106786
[TBL] [Abstract][Full Text] [Related]
40. A comparative study of the effects of temperature, time and factor VIII assay type on factor VIII activity in cryoprecipitate in Iran.
Omidkhoda A; Tabatabaei MR; Atarodi K; Karimi K; Froushani AR; Pourfathollah AA
Blood Transfus; 2011 Oct; 9(4):394-9. PubMed ID: 21839017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
